Combination clinical trials
Combination is named as an intervention in 4 current clinical trials in our China, Italy, Denmark and Egypt registers. 3 are recruiting patients now. The most common phase is Observational. The sponsor with the most trials is Sun Yat-sen University (1). The most-studied condition is Type 2 Diabetes.
Patient leaflets for Combination
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Combination
4 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
NCT04341181 · ClinicalTrials.gov ↗ · Cancer, Tumors, Neoplasms
|
Phase 2 | Recruiting | Ulrik Lassen | Denmark |
|
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT06008691 · ClinicalTrials.gov ↗ · Non-Hodgkin Lymphoma, B-cell
|
Observational | Recruiting | Fondazione Italiana Linfomi - ETS | Italy |
|
Magnesium Sulfate as an Adjuvant to Lidocaine in MPDS Trigger Point Injections Assessed by VAS and sEMG.
NCT07390851 · ClinicalTrials.gov ↗ · Myofascial Pain Dysfunction Syndrome
|
Not applicable | Recruiting | Cairo University | Egypt |
|
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes
NCT07003191 · ClinicalTrials.gov ↗ · Type 2 Diabetes
|
Observational | Active, closed | Sun Yat-sen University | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Combination
7 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Sun Yat-sen University | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Ulrik Lassen | 1 |
| Cairo University | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 1 | 0 |
| Clinical trials in Italy | 1 | 1 |
| Clinical trials in Denmark | 1 | 1 |
| Clinical trials in Egypt | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Combination trials
How many clinical trials are testing Combination?
4 current trials in our China, Italy, Denmark and Egypt registers name Combination as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Combination trials recruiting patients?
Yes. 3 of the 4 trials are recruiting: 1 with sites in Italy, 1 with sites in Denmark and 1 with sites in Egypt. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Combination clinical trials?
Sun Yat-sen University (1), Fondazione Italiana Linfomi - ETS (1), Ulrik Lassen (1) and Cairo University (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Combination works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Combination works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Combination (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.